This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Flecainide |
| Description |
An antiarrhythmic drug used in the treatment of ventricular tachycardia and premature ventricular contractions. |
| Therapeutic Low |
0.1700 |
| Therapeutic High |
1.8800 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
12.00 |
| Half Life High |
27.00 |
| VOD Low |
9.00 |
| VOD High |
10.00 |
| Toxic Level |
2.000 |
| Lethal Level |
10.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
The most common adverse effects of nonfatal overdose are nausea/vomiting, bradycardia, and hypotension. |